Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
3/23/2021
Citrine Granted Clinical Trial Waiver for Narcolepsy Drug Wakix and ...
3/22/2021
Sesen and Qilu Announce Chinese IND Approval for Vicineum
3/18/2021
Ping An Good Doctor: Cross-Sectional Survey
3/17/2021
Pfizer To Be Granted Priority Review for Its NDA of Abrocitinib
3/16/2021
Snapshot of Biological Product Registration and Launch in China Last Y...
3/16/2021
Remegen Wins China Approval for Lupus Drug Telitacicept
3/16/2021
China Approves Another COVID-19 Vaccine for Emergency Use
3/12/2021
NHC Issues the Pediatric Vaccine Inoculation Procedures and Notes of t...
3/9/2021
Sinopharm Faces Battle to Turn Covid Vaccine into a Global Success
3/8/2021
Eli Lilly Launches Verzenio (Abemaciclib) in China
3/4/2021
SciClone Launches IPO on the Main Board of the Hong Kong Stock Exchang...
3/3/2021
ADC Developer Suzhou Medilink Therapeutics Secures $50M in A1 Financin...
3/2/2021
ADC Developer Suzhou Medilink Therapeutics Secures $50M in A1 Financin...
3/1/2021
NMPA Solicits Comments on the Draft Measures for Control of Vaccine Pr...
2/25/2021
China Approves Two More Domestic COVID-19 Vaccines
2/8/2021
Sinovac's COVID-19 Vaccine Granted Conditional Approval in China as WH...
2/8/2021
IQVIA Conducts Survey of Physician Behaviors at the Internet Clinic Pl...
2/8/2021
Kantar: Chinese Physicians' Digital Behaviour During COVID-19 Outbreak
2/2/2021
AZ's Chinese Partner Kangtai Bio Expects to Make 400M COVID-19 Vaccine...
2/1/2021
GSK Ends COVID-19 Vaccine Partnership with Clover
2/1/2021
Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of...
2/1/2021
Legend Biotech Announces BCMA CAR-T Cilta-cel Accepted for Accelerated...
1/28/2021
Citrine Med and Diurnal Announce Strategic Partnership for Pediatric ...
1/28/2021
Bio-Thera Files Biologics License Application Avastin Biosimilar with ...
1/22/2021
Everest Medicines Granted Clinical Trial Approval of Sacituzumab Govi...
1/22/2021
Eli Lilly's NDA for Cyramza (Ramucirumab) Accepted in China
1/21/2021
Sinovac Increases Vaccine Production to Ensure Global Supply
1/21/2021
Chinese Civil Code Introduces Punitive Damages Against IP Infringement
1/19/2021
Innovent Announces an Out-license Deal with PT Etana to Launch Bevaciz...
1/13/2021
Sesen Bio and Qilu Pharma Announce Acceptance IND for Vicineum in C...
Page:
11
/
68
Total number of articles:
2025
:
[First]
[<<]
[9]
[10]
[11]
[12]
[13]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit